Inventor · disambiguated record
Einar M. Sigurdsson
Also filed as: SIGURDSSON EINAR · SIGURDSSON EINAR M
24 granted patents·7 pending applications·417 citations·filing 2001–2024
96Inventor score
Top patents by PatentIndex Score
31 records- 0198US8012936B2Tau fragments for immunotherapyUNIV NEW YORK·Filed 2007·Granted Sep 6, 2011·75 cites·4 claims
- 0297US6713450B2Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2001·Granted Mar 30, 2004·132 cites·30 claims
- 0396US11519920B2Tau imaging ligands and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2020·Granted Dec 6, 2022·3 cites·15 claims
- 0495US10859582B2Tau imaging ligands and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2018·Granted Dec 8, 2020·6 cites·20 claims
- 0595US9777056B2Immunotherapy for clearing pathological tau conformersUNIV NEW YORK·Filed 2015·Granted Oct 3, 2017·9 cites·15 claims
- 0693US7479482B2Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid β, prion protein, amylin, α-synuclein, or polyglutamine repeats for induction of an immune response theretoUNIV NEW YORK·Filed 2002·Granted Jan 20, 2009·40 cites·8 claims
- 0791US9139643B2Immunotherapy for clearing pathological tau conformersSIGURDSSON EINAR·Filed 2011·Granted Sep 22, 2015·15 cites·4 claims
- 0891US8748386B2Immunological targeting of pathological Tau proteinsSIGURDSSON EINAR M·Filed 2010·Granted Jun 10, 2014·23 cites·23 claims
- 0989US10358503B2Antibody-based molecules selective for the {P}Ser404 epitope of Tau and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2016·Granted Jul 23, 2019·5 cites·21 claims
- 1089US7700107B2Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2008·Granted Apr 20, 2010·12 cites·4 claims
- 1189US6821504B2Detection of alzheimer's amyloid by magnetic resonance imagingUNIV NEW YORK·Filed 2002·Granted Nov 23, 2004·45 cites·36 claims
- 1288US11958898B2Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2021·Granted Apr 16, 2024·1 cites·14 claims
- 1388US11787854B2Immunological targeting of pathological tau proteinsUNIV NEW YORK·Filed 2020·Granted Oct 17, 2023·1 cites·13 claims
- 1488US10132818B2Tau imaging ligands and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2015·Granted Nov 20, 2018·6 cites·19 claims
- 1584US7632816B2Treatment of Alzheimer amyloid depositionUNIV NEW YORK·Filed 2004·Granted Dec 15, 2009·18 cites·6 claims
- 1683US9409146B2Method for treating amyloid diseaseUNIV NEW YORK·Filed 2012·Granted Aug 9, 2016·3 cites·3 claims
- 1783US2025059265A1Alpha-synuclein single domain antibodiesUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 1882US10988528B2Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathyUNIV NEW YORK·Filed 2016·Granted Apr 27, 2021·3 cites·17 claims
- 1981US7427655B2Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid depositsUNIV NEW YORK·Filed 2003·Granted Sep 23, 2008·12 cites·9 claims
- 2072US8685718B2Mucosal immunization to prevent prion infectionWISNIEWSKI THOMAS·Filed 2004·Granted Apr 1, 2014·5 cites·15 claims
- 2172US8318175B2Method for treating amyloid diseaseFRANGIONE BLAS·Filed 2009·Granted Nov 27, 2012·3 cites·7 claims
- 2270US12162929B2Alpha-synuclein single domain antibodiesUNIV NEW YORK·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 2370US2009163420A1Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response theretoUNIV NEW YORK·Filed 2008·Application pending·0 cites
- 2465US2020190173A1Immunotherapy for Clearing Pathological Tau ConformersUNIV NEW YORK·Filed 2019·Application pending·0 cites
- 2561US9700607B2Mucosal immunization to prevent prion infectionUNIV NEW YORK·Filed 2014·Granted Jul 11, 2017·0 cites·14 claims
- 2661US2014302046A1Immunological Targeting of Pathological Tau ProteinsUNIV NEW YORK·Filed 2014·Application pending·0 cites
- 2760US2018002414A1Immunotherapy for Clearing Pathological Tau ConformersUNIV NEW YORK·Filed 2017·Application pending·0 cites
- 2856US2017183400A1Immunological Targeting of Pathological Tau ProteinsUNIV NEW YORK·Filed 2017·Application pending·0 cites
- 2954US12365724B2Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 and methods of detecting thereofUNIV NEW YORK·Filed 2019·Granted Jul 22, 2025·0 cites·18 claims
- 3050US12398201B2Tau single domain antibodiesUNIV NEW YORK·Filed 2019·Granted Aug 26, 2025·0 cites·34 claims
- 3145US2007010435A1Method for treating amyloid diseaseUNIV NEW YORK·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →